...
首页> 外文期刊>Langmuir: The ACS Journal of Surfaces and Colloids >Self-Assembled Polymer/Inorganic Hybrid Nanovesicles for Multiple Drug Delivery To Overcome Drug Resistance in Cancer Chemotherapy
【24h】

Self-Assembled Polymer/Inorganic Hybrid Nanovesicles for Multiple Drug Delivery To Overcome Drug Resistance in Cancer Chemotherapy

机译:自组装的聚合物/无机杂化纳米囊泡的多种药物输送,以克服癌症化学疗法中的耐药性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

With the aim to develop a facile strategy to prepare functional drug carriers to overcome multidrug resistance (MDR), we prepared heparin/protamine/calcium carbonate (HP/PS/CaCO3) hybrid nanovesicles with enhanced cell internalization, good serum stability, and pH sensitivity for drug delivery. All the functional components including protamine to improve the cell uptake, heparin to enhance the stability, and CaCO3 to improve drug loading and endow the system with pH sensitivity were introduced to the nanovesicles by self-assembly in an aqueous medium. An antitumor drug (doxorubicin, DOX) and a drug resistance inhibitor (tariquidar, TQR) were coloaded in the nanovesicles during self-assembly preparation of the nanovesicles. The drug loaded nanovesicles, which had a mean size less than 200 nm, exhibited a pH-sensitive drug release behavior. In vitro study was carried out in both nonresistant cells (HeLa and MCF-7) and drug-resistant cancer cells (MCF-7/ADR). Because of the enhanced intracellular and nuclear drug accumulation through effective inhibition of the P-gp efflux transporter, DOX/TQR coloaded nanovesicles showed significantly improved tumor cell inhibitory efficiency, especially for drug-resistant cells. These results suggest the self-assembled nanovesicles have promising applications in multidrug delivery to overcome drug resistance in tumor treatments.
机译:为了开发一种制备功能性药物载体以克服多药耐药性(MDR)的简便策略,我们制备了肝素/鱼精蛋白/碳酸钙(HP / PS / CaCO3)杂合纳米囊泡,具有增强的细胞内化作用,良好的血清稳定性和pH敏感性用于药物输送。通过在水介质中自组装,将所有功能成分包括鱼精蛋白以改善细胞摄取,肝素以增强稳定性以及CaCO3以改善药物载量并使系统具有pH敏感性,将其引入纳米囊泡。在纳米囊泡的自组装制备过程中,将抗肿瘤药(阿霉素,DOX)和耐药抑制剂(塔利奎达,TQR)共装载在纳米囊泡中。平均尺寸小于200nm的载有药物的纳米囊泡表现出pH敏感的药物释放行为。在非耐药性细胞(HeLa和MCF-7)和耐药性癌细胞(MCF-7 / ADR)中均进行了体外研究。由于通过有效抑制P-gp外排转运蛋白增强了细胞内和核内药物的积累,DOX / TQR共载纳米囊泡显着提高了肿瘤细胞的抑制效率,尤其是对于耐药细胞。这些结果表明,自组装的纳米囊泡在多药递送中克服了肿瘤治疗中的耐药性具有广阔的应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号